Searched for
BRONCHOSPASM
Pope Francis, in setback, had 'isolated' breathing crisis, Vatican saysPope Francis experienced an isolated breathing crisis and vomiting with aspiration in Gemelli hospital on Friday, with a sudden worsening o...
US unit of India's Cipla recalls six batches of bronchospasm inhalerIndian pharmaceutical company Cipla has recalled six batches of its Albuterol Sulfate HFA Inhalation Aerosol in the US due to a container d...
Lupin inks pact to acquire two inhalation brands from Sunovion for USD 75 mnThe acquisition of these two brands will expand the company's inhalation product portfolio in the US and strengthen its presence in the res...
Zydus Cadila gets USFDA nod for generic drugAlbuterol is a bronchodilator which helps open up the airways in the lungs to make it easier to breathe. The medicine is used to treat and ...
Pharma’s perennial underperformer gets a shot in the arm. Can it deliver?The stock has gained 64 per cent from March lows and 27 per cent year to date, but still 54 per cent down from its all-time high of Rs 2,12...
Lupin gets US health regulator's approval for asthmatic symptoms prevention drugThe approved product is a generic version of ProAir HFA of Teva Branded Pharmaceutical Products R&D, Inc. In a regulatory filing, Lupin sai...
Spraying disinfectants can be 'harmful', says WHOSpraying chlorine or other toxic chemicals on people can cause eye and skin irritation, bronchospasm and gastrointestinal effects. The orga...
Spraying of disinfectant on people physically, psychologically harmful: Health ministryThe Union Health Ministry has issued an advisory against spraying of disinfectant on people for Covid-19 management, saying it was physical...
Spraying of disinfectant on people 'physically and psychologically harmful': Health ministryThe ministry said it has received many queries regarding the efficacy (if any) of use disinfectants such as sodium hypochlorite spray used ...
The Week That Was in 10 Stocks: Pharma shares on a tear; IDBI, IndusInd Bank rallyA second stimulus package India is poised to announce in coming days will be worth around Rs 1 lakh crore.
Market Movers: M&M, Maruti, Cipla soar; 19 stocks turn ‘overbought’As many as 19 stocks turned ‘overbought’ as they crossed the 70 mark on RSI indicator.
Cipla hits 15% upper circuit as USFDA gives final approval to Albuterol Inhalation AerosolFollowing the development, the scrip hit its 15 per cent upper circuit limit at Rs 589.95.
Cipla gets final approval from USFDA for Albuterol Sulfate Inhalation AerosolIn a regulatory filing the company said "it has received final approval for its Abbreviated New Drug Application (ANDA) for Albuterol Sulfa...
World Asthma Day: Long-term usage of inhalers can have adverse side effectsNot only prevalent in developed countries, but it is also a major problem in the developing countries.
- FDA approves Merck's new lung drug Dulera
Merck & Co Inc's new two-in-one respiratory drug Dulera has been approved by the US Food and Drug Administration, the US company said on Th...
- Pharmaland: sometimes it’s all in the name
India will have to get its entire healthcare and pharma sector regulatory structure in place
- Local cos line up for Merck unit
The bidding process for the generics business of German pharmaceutical corporation Merck is set to begin in a few days. The advisors to Mer...